Publications
3 shownTriple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopin...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 14,431
- Institution
- University of Hong Kong
External Links
Identifiers
- ORCID
- 0000-0002-9549-7384
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.